can you take glp 1 with breast cancer GLP-1 use linked to lower incidence SABCS 2025: Can GLP-1s Help

130 MurakamiA.TakahashiD.KinoshitaT.KoshimizuK.KimH

A positive surprise is that the approval was for a tablet formulation, which is less expensive to manufacture than the capsule versions studied by Lilly during clinical trials, David Risinger, a senior managing director and senior research analyst covering diversified biopharmaceuticals at Leerink Partners, shared in a research note

10.1038/onc.2015.381 210 VanhoveK.DerveauxE.GraulusG

Novo Nordisk to cut GLP-1 prices in tough US market Novo Nordisk has turned to pricing as a means to shore up its position in the increasingly competitive market for GLP-1 agonist therapies in the US, promising to slash the monthly cost of its semaglutide-based Wegovy weight-loss therapy and Ozempic for type 2 diabetes

A study examined samples from several different vendors and found that they contained unknown impurities ranging from 4.1 to 5.9%